multiple sclerosis(5) Safety(4) Effectiveness(3) myasthenia gravis(2) Epidemiology(2) COVID-19(2) Relapsing–remitting multiple sclerosis(2) Diagnosis(2) Scotland(1) Relapsing–remitting multiple sclerosis(1) Optic coherence tomography (OCT)(1) Cognitive impairment(1) poliomyelitis(1) Alemtuzumab(1) Myasthenic crisis(1) Multiple sclerosis (MS)(1) Post-COVID-Fatigue(1) Post-COVID-19 vaccine syndrome (PVS)(1) real-world data(1) Cerebrospinal fluid (CSF)(1) Demyelination(1) Natalizumab(1) Therapeutic Drug Monitoring(1) Magnetic resonance imaging (MRI)(1) acute cerebellitis(1) immunoglobulins(1) Prediction model(1) selected(1) MOG antibody-associated encephalomyelitis (MOG-EM)(1) RT-QuIC(1)